A detailed history of International Assets Investment Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, International Assets Investment Management, LLC holds 10,410 shares of GMAB stock, worth $214,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,410
Holding current value
$214,966
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$23.84 - $28.48 $248,174 - $296,476
10,410 New
10,410 $427,000
Q4 2023

Jan 24, 2024

BUY
$27.94 - $35.44 $349,613 - $443,460
12,513 New
12,513 $393,000
Q2 2021

Jul 14, 2021

SELL
$32.88 - $44.57 $6,904 - $9,359
-210 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$33.66 - $40.76 $7,068 - $8,559
210 New
210 $8.54 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.